Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2016

View Archived Issues

AZD-7325, increases test stimulus intensity at 2-h post-dose in a phase I crossover study

Exploring optimal dosing of lonafarnib with ritonavir for the treatment of chronic delta hepatitis

DWN-10899, a novel Nav1.7 blocker significantly blocks neuropathic pain in mouse model

Sanford-Burnham Medical Research Institute patents APJ agonists

Janssen Pharmaceutica discloses TARPgamma8 modulators

Eli Lilly and Company describes BACE1 inhibitors

Chinese researchers develop antiviral agents

Sanford-Burnham Medical Research Institute presents EphA4 inhibitors

Gilead Sciences returns GS-4774 rights to GlobeImmune

Janssen submits application to FDA seeking approval of guselkumab

Agilis Biotherapeutics' AGIL-AADC wins FDA rare pediatric disease designation

FDA approves Intrarosa to treat dyspareunia in postmenopausal women

Endo's CCH significantly improves cellulite in phase II study

Resverlogix's apabetalone shows favorable PK profile in severe renal impairment

Cellectar Biosciences reports advances in Pierre Fabre research collaboration

ProMetic Life Sciences's PBI-4050 shows efficacy in phase II study in IPF

Celgene acquires marizomib assets from Triphase Accelerator

Novan reports promising preclinical data on SB-414 for psoriasis

Immune Pharmaceuticals secures new financing

Namodenoson approved as generic name for CF-102

Launch of International PSC Genome Project for primary sclerosing cholangitis

FDA awards fast track designation to Eisai's BACE inhibitor for Alzheimer's

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...